Institutional Ownership Vaxcyte, Inc. (PCVX)
This table provides information about the institutional ownership of Vaxcyte, Inc. (PCVX). We have compiled data on the 344 institutions that hold shares in the stock, with a total of 136 Million shares, which have been reported (via 13F filing form) to have a value of $4.63 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Ra Capital Management, L.P.
Boston, MA |
May 15, 2025 Q1 2025 |
12,189,149
shares
|
$414 Million
9.56% of portfolio
|
Q1 2025
Added 40.28%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
12,043,805
shares
|
$409 Million
0.01% of portfolio
|
Q1 2025
Added 0.69%
|
|
Janus Henderson Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
11,765,481
shares
|
$400 Million
0.25% of portfolio
|
Q1 2025
Added 11.25%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
9,939,846
shares
|
$338 Million
0.02% of portfolio
|
Q2 2024
Added 4.49%
|
|
Wellington Management Group LLP
Boston, MA |
May 13, 2025 Q1 2025 |
6,416,930
shares
|
$218 Million
0.05% of portfolio
|
Q1 2025
New holding
|
|
Capital Research Global Investors
Los Angeles, CA |
May 12, 2025 Q1 2025 |
6,110,108
shares
|
$208 Million
0.05% of portfolio
|
Q1 2025
Reduced 1.62%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
4,407,683
shares
|
$150 Million
0.01% of portfolio
|
Q1 2025
Reduced 2.9%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
3,542,007
shares
|
$120 Million
0.02% of portfolio
|
Q1 2025
Reduced 10.71%
|
|
Kynam Capital Management, LP
Princeton, NJ |
May 15, 2025 Q1 2025 |
3,200,000
shares
|
$109 Million
10.18% of portfolio
|
Q1 2025
Added 36.94%
|
|
Franklin Resources Inc
San Mateo, CA |
May 13, 2025 Q1 2025 |
3,089,032
shares
|
$105 Million
0.04% of portfolio
|
Q1 2025
Added 7.66%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
2,869,054
shares
|
$97.5 Million
0.01% of portfolio
|
Q1 2025
Added 2.36%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
May 14, 2025 Q1 2025 |
2,702,691
shares
|
$91.8 Million
0.07% of portfolio
|
Q1 2025
Reduced 5.52%
|
|
Westfield Capital Management CO LP
Boston, MA |
May 09, 2025 Q1 2025 |
2,155,137
shares
|
$73.2 Million
0.42% of portfolio
|
Q1 2025
Reduced 16.04%
|
|
Abingworth LLP
London, X0 |
Feb 10, 2023 Q4 2022 |
2,019,057
shares
|
$68.6 Million
32.11% of portfolio
|
Q4 2022
Reduced 51.57%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
1,900,179
shares
|
$64.5 Million
0.01% of portfolio
|
Q1 2025
Added 9.48%
|
|
Alliancebernstein L.P.
New York, NY |
May 15, 2025 Q1 2025 |
1,704,211
shares
|
$57.9 Million
0.02% of portfolio
|
Q1 2025
Reduced 4.22%
|
|
Paradigm Biocapital Advisors LP
New York, NY |
May 15, 2025 Q1 2025 |
1,696,481
shares
|
$57.6 Million
3.28% of portfolio
|
Q1 2025
Added 19.24%
|
|
Commodore Capital LP
New York, NY |
May 15, 2025 Q1 2025 |
1,650,000
shares
|
$56.1 Million
6.1% of portfolio
|
Q1 2025
Added 1.54%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,480,747
shares
|
$50.3 Million
0.09% of portfolio
|
Q2 2023
Added 120.98%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
1,333,382
shares
|
$45.3 Million
0.01% of portfolio
|
Q1 2025
Reduced 0.63%
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
1,255,827
shares
|
$42.7 Million
0.01% of portfolio
|
Q1 2025
Added 7.7%
|
|
Clearbridge Investments, LLC
New York, NY |
May 13, 2025 Q1 2025 |
1,220,455
shares
|
$41.5 Million
0.04% of portfolio
|
Q1 2025
Added 10.7%
|
|
Lee Ainslie
Maverick Capital LTD | Dallas, Tx
|
May 15, 2025 Q1 2025 |
1,208,093
shares
|
$41 Million
0.9% of portfolio
|
Q1 2025
Added 0.52%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 09, 2025 Q1 2025 |
1,197,688
shares
|
$40.7 Million
0.02% of portfolio
|
Q1 2025
Reduced 1.24%
|
|
Goldman Sachs Group Inc
New York, NY |
May 16, 2025 Q1 2025 |
1,147,302
shares
|
$39 Million
0.01% of portfolio
|
Q1 2025
Reduced 3.53%
|